Concepedia

David Dobrzanski

DD

Statistics

Publications

3

Citations

313

H-Index

3

Active since

1991

Affiliations

Bristol Hospital(Current)

Amarillo VA Health Care System

Harrington Cancer Center

Texas Tech University Health Sciences Center

Texas Tech University

David Dobrzanski is an author at Bristol Hospital specializing in immunology, ovarian cancer, and medicine.

Top concepts

Publications per year

1991–2011

3

Publications

3

Two distinct bombesin receptor subtypes are expressed and functional in human lung carcinoma cells.

Martha H. Corjay, David Dobrzanski, James M. Way et al. · Journal of Biological Chemistry · 1991 · 229 citations · Full text

Immunotherapy with IL-10- and IFN-γ-producing CD4 effector cells modulate “Natural” and “Inducible” CD4 TReg cell subpopulation levels: observations in four cases of patients with ovarian cancer

Mark J. Dobrzanski, Kathleen Rewers‐Felkins, Khaliquzzaman Samad et al. · Cancer Immunology Immunotherapy · 2011 · 48 citations

, , +12

Autologous MUC1-specific Th1 effector cell immunotherapy induces differential levels of systemic TReg cell subpopulations that result in increased ovarian cancer patient survival

Mark J. Dobrzanski, Kathleen Rewers‐Felkins, Imelda S. Quinlin et al. · Clinical Immunology · 2009 · 36 citations

, , +8

1–3 of 3